Merck Sharp & Dohme Revenue, Growth & Competitor Profile

DBA MERCK

Company Profile & Annual Report for Merck Sharp & Dohme

Access the complete profile.

Merck Sharp & Dohme Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 54191 Marketing Research & Public Opinion Polling
Address	126 E Lincoln Ave Rahway, NJ 07065

Note: Revenues for privately held companies are statistical evaluations.


Merck Sharp & Dohme's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Merck Sharp & Dohme's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Merck Sharp & Dohme is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Merck Sharp & Dohme Annual Revenue and Growth Rate

Merck Sharp & Dohme	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Over $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Merck Sharp & Dohme's revenues are gauged from an analysis of company filings.

Merck Sharp & Dohme's Income Statement (based on Industry Averages)

Merck Sharp & Dohme P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Merck Sharp & Dohme is developing and marketing. Merck Sharp & Dohme doesn't have any recent trademark applications, indicating Merck Sharp & Dohme is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
WELIREG + YOU Personal support services for cancer patients, namely, emotional support and emotional counseling	12/19/2023
KEYTRUDA HYLURO Pharmaceutical preparations for the prevention and treatment of cancer	11/06/2023
KEYTRUDA HYAQ Pharmaceutical preparations for the prevention and treatment of cancer	11/06/2023

See all trademarks and details in the Full Report.

Market Share of Merck Sharp & Dohme's Largest Competitors

A competitive analysis shows these companies are in the same general field as Merck Sharp & Dohme, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Merck Sharp & Dohme. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MERCK SHARP & DOHME	Rahway, NJ	100
MERCK	Rahway, NJ	95
ZOETIS	Parsippany, NJ	26
TEVA PHARMACEUTICALS USA	Parsippany, NJ	18
GLAXOSMITHKLINE CONSUMER HEALTHCARE	Warren, NJ	10
CAMBREX	East Rutherford, NJ	5

Future Competition: Merck Sharp & Dohme's Fastest Growing Competitors

These companies are in the same general field as Merck Sharp & Dohme and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)